Countries across Europe are restricting sales of OTC drugs in response to COVID-19 to maintain supply and counteract stockpiling. The approach varies widely across the region: countries such as Germany and France have introduced strict limits, while others, such as the UK and Ireland, have not ordered official restrictions. HBW Insight presents an analysis of the actions taken by 14 European countries to the upsurge in demand for OTCs.
• Source: Shutterstock
COVID-19 is spreading rapidly across Europe leading to an unprecedented upsurge in demand for popular OTC drugs which can be used to treat some of the virus’ symptoms.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
